Cited by — Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Cost-effectiveness analysis of pneumococcal conjugate vaccines, PCV21 vs PCV20, in adults aged ≥60 years in Germany.
No admitted local citation edges point to this work yet.
